Open access
104
Views
35
CrossRef citations to date
0
Altmetric
Original Research
Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD
Dennis E Doherty1 Division of Pulmonary, Critical Care, and Sleep Medicine, University of Kentucky, Lexington, KYCorrespondence[email protected]
, Donald P Tashkin2 David Geffen School of Medicine at UCLA, Los Angeles, CA
, Edward Kerwin3 Clinical Research Institute of Southern Oregon, Medford, OR
, Barbara A Knorr4 Merck Sharp & Dohme Corp, Whitehouse Station, NJ, USA
, Tulin Shekar4 Merck Sharp & Dohme Corp, Whitehouse Station, NJ, USA
, Sibabrata Banerjee4 Merck Sharp & Dohme Corp, Whitehouse Station, NJ, USA
& Heribert Staudinger4 Merck Sharp & Dohme Corp, Whitehouse Station, NJ, USA
show all
Pages 57-71
|
Published online: 03 Feb 2012
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.